These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34611475)

  • 1. Opposing effects of BRCA1 mRNA expression on patient survival in breast and colorectal cancer and variations among African American, Asian, and younger patients.
    Leaf S; Carlsen L; El-Deiry WS
    Oncotarget; 2021 Sep; 12(20):1992-2005. PubMed ID: 34611475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Regulatory Factors and Immune-Associated Patterns to Decipher Common and
    Li Y; Dong W; Zhang P; Zhang T; Ma L; Qu M; Ma X; Zhou X; He Q
    Front Cell Dev Biol; 2021; 9():750897. PubMed ID: 34733851
    [No Abstract]   [Full Text] [Related]  

  • 3. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
    Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
    World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Overall Survival and Treatment Patterns in Two Large Population-Based Cohorts of Patients with Breast and Colorectal Cancer.
    Abbema DV; Vissers P; Vos-Geelen J; Lemmens V; Janssen-Heijnen M; Tjan-Heijnen V
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31450842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
    Zhang Y; Zhang Y; Wang J; Yang J; Yang G
    Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
    Wang F; Liu Y; Jiang J; Qin Y; Ge X; Li J; Qi X; Mao Y
    Int J Clin Exp Pathol; 2018; 11(1):216-223. PubMed ID: 31938103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PALB2 as a potential prognostic biomarker for colorectal cancer.
    Pan W; Lu K; Wang W; Yao J; Hou Y
    Comput Biol Chem; 2020 May; 87():107289. PubMed ID: 32497983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.
    Abdulla MH; Valli-Mohammed MA; Al-Khayal K; Al Shkieh A; Zubaidi A; Ahmad R; Al-Saleh K; Al-Obeed O; McKerrow J
    Oncol Rep; 2017 Jun; 37(6):3175-3180. PubMed ID: 28440429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression.
    Chida K; Oshi M; Roy AM; Sato T; Takabe MP; Yan L; Endo I; Hakamada K; Takabe K
    Breast Cancer Res Treat; 2024 Jul; ():. PubMed ID: 38972017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer.
    Li X; Zhang Q; Zhao L; Jiang L; Qi A; Wei Q; Song X; Wang L; Zhang L; Zhao Y; Lv X; Wei M; Zhao L
    J Cancer; 2020; 11(8):2139-2149. PubMed ID: 32127941
    [No Abstract]   [Full Text] [Related]  

  • 11. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls.
    Akcay IM; Celik E; Agaoglu NB; Alkurt G; Kizilboga Akgun T; Yildiz J; Enc F; Kir G; Canbek S; Kilic A; Zemheri E; Ezberci F; Ozcelik M; Dinler Doganay G; Doganay L
    Int J Cancer; 2021 Jan; 148(2):285-295. PubMed ID: 32658311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.
    Chen HM; Lin CC; Chen WS; Jiang JK; Yang SH; Chang SC; Ho CL; Yang CC; Huang SC; Chao Y; Liao TT; Hwang WL; Teng HW
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic significance of Fanconi anemia group D2 protein and breast cancer type 1 susceptibility protein in familial and sporadic breast cancer.
    Feng L; Jin F
    Oncol Lett; 2019 Apr; 17(4):3687-3700. PubMed ID: 30881493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.
    Hallajian Z; Mahjoubi F; Nafissi N
    Breast Cancer; 2017 Jul; 24(4):624-634. PubMed ID: 28058614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
    Yang J; Tong Q; Zhang Y; Yuan S; Gao Y; Deng K; Wang Y; Lu J; Xie X; Zhang Z; Zhang J
    J Cancer; 2021; 12(20):6170-6181. PubMed ID: 34539890
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patient.
    Cai FF; Chen S; Wang MH; Lin XY; Zhang L; Zhang JX; Wang LX; Yang J; Ding JH; Pan X; Shao ZM; Biskup E
    Oncotarget; 2016 May; 7(19):27499-510. PubMed ID: 27027444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
    Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
    J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of trefoil factor 3 is decreased in colorectal cancer.
    Espinoza I; Agarwal S; Reddy A; Shenoy V; Subramony C; Sakiyama M; Fair L; Poosarla T; Zhou X; Shannon Orr W; Lahr C; Bae S; Al Diffalha S; Manne U; Gomez CR
    Oncol Rep; 2021 Jan; 45(1):254-264. PubMed ID: 33210724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and prognostic factors in BRCA1-associated breast cancer.
    Brekelmans CT; Seynaeve C; Menke-Pluymers M; Brüggenwirth HT; Tilanus-Linthorst MM; Bartels CC; Kriege M; van Geel AN; Crepin CM; Blom JC; Meijers-Heijboer H; Klijn JG
    Ann Oncol; 2006 Mar; 17(3):391-400. PubMed ID: 16322115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer.
    Garcia JM; Rodriguez R; Dominguez G; Silva JM; Provencio M; Silva J; Colmenarejo A; Millan I; Muñoz C; Salas C; Coca S; España P; Bonilla F
    Gut; 2003 Dec; 52(12):1756-63. PubMed ID: 14633957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.